Literature DB >> 20024606

Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors.

Kumar U Kotlo1, Mark M Rasenick, Robert S Danziger.   

Abstract

Guanylyl cyclases (GCs), a ubiquitous family of enzymes that metabolize GTP to cyclic GMP (cGMP), are traditionally divided into membrane-bound forms (GC-A-G) that are activated by peptides and cytosolic forms that are activated by nitric oxide (NO) and carbon monoxide. However, recent data has shown that NO activated GC's (NOGC) also may be associated with membranes. In the present study, interactions of guanylyl cyclase A (GC-A), a caveolae-associated, membrane-bound, homodimer activated by atrial natriuretic peptide (ANP), with NOGC, a heme-containing heterodimer (alpha/beta) beta1 isoform of the beta subunit of NOGC (NOGCbeta1) was specifically focused. NOGCbeta1 co-localized with GC-A and caveolin on the membrane in human kidney (HK-2) cells. Interaction of GC-A with NOGCbeta1 was found using immunoprecipitations. In a second set of experiments, the possibility that NOGCbeta1 regulates signaling by GC-A in HK-2 cells was explored. ANP-stimulated membrane guanylyl cyclase activity (0.05 +/- 0.006 pmol/mg protein/5 min; P < 0.01) and intra cellular GMP (18.1 +/- 3.4 vs. 1.2 +/- 0.5 pmol/mg protein; P < 0.01) were reduced in cells in which NOGCbeta1 abundance was reduced using specific siRNA to NOGCbeta1. On the other hand, ANP-stimulated cGMP formation was increased in cells transiently transfected with NOGCbeta1 (530.2 +/- 141.4 vs. 26.1 +/- 13.6 pmol/mg protein; P < 0.01). siRNA to NOGCbeta1 attenuated inhibition of basolateral Na/K ATPase activity by ANP (192 +/- 22 vs. 92 +/- 9 nmol phosphate/mg protein/min; P < 0.05). In summary, the results show that NOGCbeta1 and GC-A interact and that NOGCbeta1 regulates ANP signaling in HK-2 cells. The results raise the novel possibility of cross-talk between NOGC and GC-A signaling pathways in membrane caveolae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024606      PMCID: PMC2863078          DOI: 10.1007/s11010-009-0352-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  NOSIP, a novel modulator of endothelial nitric oxide synthase activity.

Authors:  J Dedio; P König; P Wohlfart; C Schroeder; W Kummer; W Müller-Esterl
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

2.  Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes.

Authors:  M Russwurm; N Wittau; D Koesling
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

Review 3.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

4.  Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release.

Authors:  K S Russell; M P Haynes; T Caulin-Glaser; J Rosneck; W C Sessa; J R Bender
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

6.  Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.

Authors:  Alicia H Correa; Marcelo R Choi; Mariela Gironacci; María S Valera; Belisario E Fernández
Journal:  Regul Pept       Date:  2006-09-26

7.  Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitric-oxide synthase function.

Authors:  S Cao; J Yao; T J McCabe; Q Yao; Z S Katusic; W C Sessa; V Shah
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

8.  Gene targeting and heme oxygenase-1 expression in prevention of hypertension induced by angiotensin II.

Authors:  Nader G Abraham
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

9.  Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide.

Authors:  Rosana Elesgaray; Carolina Caniffi; Daniela Rodríguez Ierace; María Florencia Visintini Jaime; Andrea Fellet; Cristina Arranz; María Angeles Costa
Journal:  Regul Pept       Date:  2008-06-08

10.  Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interface.

Authors:  André De Léan; Normand McNicoll; Jean Labrecque
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

View more
  4 in total

1.  Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.

Authors:  Bahar Hesabi; Robert S Danziger; Kumar U Kotlo
Journal:  Cell Signal       Date:  2012-01-17       Impact factor: 4.315

2.  Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.

Authors:  Kumar U Kotlo; Bahar Hesabi; Robert S Danziger
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

3.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Authors:  Yousuke T Horikawa; Mathivadhani Panneerselvam; Yoshitaka Kawaraguchi; Yasuo M Tsutsumi; Sameh S Ali; Ravi C Balijepalli; Fiona Murray; Brian P Head; Ingrid R Niesman; Timo Rieg; Volker Vallon; Paul A Insel; Hemal H Patel; David M Roth
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

4.  Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice.

Authors:  Philip G Wong; David W J Armstrong; M Yat Tse; Emily P A Brander; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2012-11-21       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.